AstraZeneca's experimental COVID-19 vaccine has shown promise in its early-stage human trials.
It was found to be safe -- and produced an immune response in clinical testing in healthy volunteers, data showed on Monday (July 20) with the strongest response seen in people who received two doses. The vaccine is part of a collaboration between AstraZeneca and scientists at Britain's University of Oxford.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en